I
Immunome, Inc. (IMNM)
NCM – Real vaqt narxi. Valyuta: USD
19.96
+0.56 (2.89%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
19.96
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 7:19 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
19.96
+0.56 (2.89%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
19.96
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 7:19 PM EDT
Immunome, Inc., biotexnologiya kompaniyasi, Qo'shma Shtatlarda antitel-dorilar kon'yugatlar va boshqa onkologik terapevtik vositalarni kashf qilish, loyihalash, ishlab chiqish, ishlab chiqarish va tijoratlashtirish bilan shug'ullanadi. Kompaniya desmoid o'smalarini davolash uchun 3-bosqich klinik sinovida bo'lgan gamma-sekretaza ingibitori Varegacestatni o'z ichiga olgan klinik aktivni ishlab chiqmoqda; va 1-bosqich klinik sinovida bo'lgan retseptor tirozin kinaziga o'xshash etilmagan retseptor 1 antitel-dorilar kon'yugatining (ADC) IM-1021ni ishlab chiqmoqda. Kompaniya, shuningdek, fibroblast aktivatsiya oqsili maqsadli radioligand terapiyasi bo'lgan IM-3050 va qattiq o'smalar uchun ADC preparati nomzodlari, jumladan IM-1617, IM-1340 va IM-1335 kabi preklinik aktivlarni ishlab chiqmoqda. Immunome, Inc. 2006 yilda tashkil etilgan va Vashingtonning Bothell shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Clay B. Siegall Ph.D. | Chairman, President & CEO |
| Dr. Jack Higgins Ph.D. | Chief Scientific Officer |
| Dr. Philip Tsai | Chief Technical Officer |
| Dr. Robert J. Lechleider M.D. | Chief Medical Officer |
| Mr. Kinney Horn | Chief Business Officer |
| Mr. Max Rosett | Chief Financial Officer |
| Mr. Roee Shahar | Executive Vice President of Commercial |
| Ms. Sandra G. Stoneman Esq., J.D. | Chief Legal Officer, General Counsel & Corporate Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-12 | 8-K | imnm-20260609.htm |
| 2026-05-12 | 10-Q | imnm-20260331.htm |
| 2026-04-24 | DEFA14A | ny20062786x2_defa14a.htm |
| 2026-04-24 | DEF 14A | ny20062786x1_def14a.htm |
| 2026-04-24 | ARS | ny20062786x3_ars.pdf |
| 2026-03-03 | S-8 | imnm-20260303.htm |
| 2026-03-03 | 8-K | imnm-20260303.htm |
| 2026-03-03 | 10-K | imnm-20251231.htm |
| 2025-12-17 | 8-K | d27244d8k.htm |
| 2025-12-15 | 8-K | d793961d8k.htm |